Wednesday, July 8, 2026

Drug profile · INN

triheptanoin

triheptanoin (DOJOLVI) is a supplement. Associated with Ultragenyx UK Limited. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 17
Pipeline programs 14
News articles 0
Drug details — triheptanoin
US status
approved
Class
Route
ORAL
Patents
17
Programs
14
Data quality
0.89

Quick answer

triheptanoin (DOJOLVI) is a supplement. Associated with Ultragenyx UK Limited. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN triheptanoin
Brand DOJOLVI
Mechanism Supplement
Route ORAL
Formulation LIQUID

Mechanism of action

Supplement

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. FAT EMULSIONS , Triheptanoin Phase 3 · Anaxis Pharma · Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
  2. Triheptanoin Phase 3 · Ultragenyx UK · Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
  3. POST Triheptanoin Phase 2 · Ultragenyx UK · Frontal Lobe Hypometabolism
  4. Triheptanoin Phase 2 · Ultragenyx UK · Glycogen Storage Disease Type V
  5. Triheptanoin Phase 2 · Ultragenyx UK · Glucose Transporter Type 1 Deficiency Syndrome
  6. Triheptanoin Phase 2 · Ultragenyx UK · Adult Polyglucosan Body Disease
  7. Triheptanoin Phase 2 · Ultragenyx UK · Glucose Transporter Type-1 Deficiency Syndrome (Glut1 DS)
  8. Triheptanoin Phase 2 · Ultragenyx UK · ALS
  1. US 11944658

    Methods of heat inactivation of adenovirus

    Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 11771748

    Methods for treating tumor-induced osteomalacia

    Expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 11753369

    Creatine prodrugs, compositions and methods of use thereof

    Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 11332438

    Creatine prodrugs, compositions and methods of use thereof

    Expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 11202822

    Methods for treating hypophosphatemic disorders

    Expires Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 11013774

    Methods of heat inactivation of adenovirus

    Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 10889607

    Sialic acid analogs

    Expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 10639360

    Methods for treating hypophosphatemic disorders

    Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 10457701

    Sialic acid analogs

    Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 10385085

    Crystal forms of sialic acid or salt or solvate thereof

    Expires Mon Aug 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 10065981

    Sialic acid analogs

    Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 9937243

    Sialylated glycoprotein compositions and uses thereof

    Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 9687532

    Sialylated glycoprotein compositons and uses thereof

    Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 9457067

    Sialylated glycoprotein compositions and uses thereof

    Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 9457068

    Sialylated glycoprotein compositions and uses thereof

    Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 9221858

    Sialic acid analogs

    Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 8840926

    Sialic acid analogs

    Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is triheptanoin?

triheptanoin (DOJOLVI) is a supplement. Associated with Ultragenyx UK Limited. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for triheptanoin?

DOJOLVI is a marketed brand name for triheptanoin. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of triheptanoin?

triheptanoin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.